MARLBOROUGH, Mass., February 20, 2025--(BUSINESS WIRE)--Global women’s health leader Hologic, Inc. (Nasdaq: HOLX) today announced that its Affirm ® Contrast Biopsy Software, which combines ...

The new disposable 7-gauge needle can be used on the system’s existing reusable device driver, enabling the Brevera system to support new functionality, simplify storage, and reduce waste. 2 Like the ...

The CE-Marked Affirm™ Prone Biopsy System Provides Enhanced 2D/3D™ Biopsy Imaging and Faster, Easier Access to the Breast [i] MARLBOROUGH, Massachusetts, March 2, 2016 /PRNewswire/ -- Hologic ...

April 21 (Reuters) - HologicBy Reuters April 21, 201612:16 PM UTCUpdated ago April 21 (Reuters) - Hologic * announces FDA clearance and commercial availability Of Affirm Prone Biopsy System, First ...

Ad hoc-Mitteilungen: Nachrichten»Hologic Announces FDA Nod, Commercial Launch Of Affirm Prone Biopsy System Push Mitteilungen FN als Startseite AFX News 21.04.2016 | 14:36 35 Leser Artikel ...

References 1 Hologic Data on File. Affirm Contrast Biopsy Instructions for Use. MAN-07748 Rev 002.

With Hologic’s powerful contrast mammography and biopsy portfolio — including the Affirm Upright Biopsy System, I-View ® 2.0 Contrast-Enhanced Mammography Software and Affirm Contrast Biopsy Software ...

References 1 Hologic Data on File. Affirm Contrast Biopsy Instructions for Use. MAN-07748 Rev 002.